India’s Smoking Cessation Landscape Moves Toward More Accessible Quit Support
India’s nicotine replacement therapy (NRT) smoking cessation aids sector was valued at USD 28.9 million in 2025 and is projected to reach USD 35.45 million by 2032, representing a 2.96% CAGR from 2026 to 2032, according to Vyansa Intelligence. The category includes nicotine gums, lozenges, patches, inhalators, and other products designed to help tobacco users manage nicotine cravings while attempting to quit.
Health and Wellness Are Influencing Quit Intent
Smoking cessation is increasingly connected with broader health and wellness goals. The report identifies a growing focus on fitness, mental wellbeing, disease prevention, and healthier lifestyles, particularly among younger urban consumers. This wider health-conscious behaviour can make structured cessation tools more relevant to people who want to move beyond an informal or self-directed attempt to stop smoking.
The changing perception of quitting also places NRT within a broader cessation journey rather than treating it solely as a standalone consumer product. Tobacco users may combine nicotine replacement with counselling, behavioural changes, digital support, or professional guidance depending on their individual circumstances.
Nicotine Gum Remains the Dominant Format
NRT gum represents 95% of the category, making it the dominant product format identified in the report. Its position is linked to affordability, familiarity, convenience, and relatively simple use, factors that are particularly important in a price-sensitive consumer environment.
The category also includes inhalators, lozenges, patches, and other NRT products. Although these formats provide alternatives for different preferences and circumstances, the strong position of gum illustrates how accessibility and everyday convenience influence product selection in India.
India’s government tobacco-dependence treatment guidance also documents nicotine gum as an NRT option, including 2 mg and 4 mg strengths, while noting that pharmacological treatment should be considered within appropriate clinical guidance.
Affordability Remains a Key Consideration
Price sensitivity is identified as one of the principal barriers to wider adoption. Smokers considering cessation may compare the cost of NRT products with cheaper self-directed quitting approaches or other available support options. This can affect whether an individual begins a structured cessation programme and whether they continue using a product for the recommended period.
The affordability issue also helps explain the strong position of nicotine gum. A comparatively familiar and accessible format can lower the initial barrier for consumers who are uncertain about using cessation aids. For the wider category, however, affordability remains closely connected with the ability to reach tobacco users across different income groups.
Pharmacies Continue to Shape Purchasing Behaviour
Retail offline channels account for 65% of sales, according to the report. Pharmacies, hospitals, and drug stores remain important access points because consumers can obtain cessation products during routine visits and may value physical availability when beginning an unfamiliar quitting process.
Offline purchasing can also support product discovery. A consumer who has decided to quit may encounter NRT while visiting a pharmacy for another reason, whereas online purchasing generally requires a more deliberate search. This makes physical distribution an important part of the category’s current purchasing structure.
Digital Channels Add Convenience
Online pharmacies, brand-owned websites, and e-commerce marketplaces form the digital side of the distribution landscape. While online channels remain smaller than offline retail, they provide additional convenience for consumers who prefer home delivery, repeat purchasing, or greater privacy.
Privacy can be particularly relevant for smoking cessation because tobacco use and attempts to quit can be personal matters. Digital channels may therefore complement physical pharmacies rather than simply replace them, giving consumers another way to access products and information as awareness of cessation options develops.
A More Structured Quit-Support System
Product availability is increasingly accompanied by formal cessation services. India’s National Tobacco Control Programme (NTCP) operates Tobacco Cessation Centres and provides pharmacotherapy and counselling through designated facilities. The programme also maintains a national tobacco quitline and mCessation services, creating additional support pathways for tobacco users who want assistance.
This infrastructure is relevant to NRT because cessation products can form part of a broader intervention that includes behavioural support. The government’s tobacco-dependence treatment guidelines describe pharmacotherapy alongside counselling and behavioural approaches rather than treating medication as an isolated solution.
Personalised Formats Are Gaining Attention
The report identifies personalised format selection as an important trend. Gum, patches, lozenges, sprays, and inhalators can provide different methods of managing nicotine cravings, allowing consumers to consider factors such as lifestyle, convenience, and personal preference.
This shift reflects a broader move toward more individualised cessation journeys. Instead of assuming that every tobacco user will respond to the same product or support mechanism, the category is increasingly being discussed in terms of matching treatment formats with individual circumstances.
The World Health Organization (WHO) similarly recommends a combination of behavioural interventions and pharmacological treatments as part of comprehensive tobacco-cessation support for adults.
Competition Remains Concentrated
The report identifies more than five companies operating in India’s NRT category, with the top three accounting for approximately 85% of the sector. Elder Pharmaceuticals Ltd, Cipla Ltd, and ITC Ltd are among the companies covered.
Such concentration means brand familiarity and distribution reach can play an important role in consumer access. At the same time, the presence of multiple NRT formats provides scope for competition around product choice, accessibility, and the ability to address different consumer preferences.
Behavioural Support Creates a Broader Opportunity
An important development identified in the report is the integration of NRT with behavioural and digital support. Smoking cessation often involves managing both nicotine dependence and established habits, routines, and triggers. Combining product-based support with counselling, follow-up, and digital interventions can therefore create a more comprehensive cessation pathway.
India already has several elements of this infrastructure. The National Tobacco Control Programme provides tobacco cessation services through dedicated centres, while its quitline and mCessation initiatives extend support beyond conventional healthcare settings.
The Road Ahead for Quit-Support Solutions
India’s NRT landscape is shaped by a combination of health awareness, affordability, distribution access, and formal cessation infrastructure. Nicotine gum currently dominates product use, while offline retail remains the principal purchasing channel. At the same time, alternative formats and digital support are creating a more varied ecosystem for people attempting to quit.
The broader direction is therefore toward accessibility and integration. For consumers, the availability of different formats and support channels can make cessation more adaptable to individual circumstances. For the healthcare system, combining behavioural assistance with evidence-based pharmacological options remains central to providing structured tobacco-dependence treatment.